Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$3.6M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 5 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 23 most recent Form 4 transactions.
| Sep 30 | ANRO | Alto Neuroscience, Inc. | MEXER◷?◆ | 24,056 | — | — | — | Open the original filing on SEC.gov |
| Sep 30 | ANRO | Alto Neuroscience, Inc. | SSELL◷? | 886 | $26.87 | $23.8K | -3.5% | Open the original filing on SEC.gov |
| Sep 30 | ANRO | Alto Neuroscience, Inc. | SSELL◷? | 23,170 | $25.78 | $597.3K | -48.1% | Open the original filing on SEC.gov |
| Sep 30 | ANRO | Alto Neuroscience, Inc. | MEXER◷? | 24,056 | $2.35 | $56.5K | +100.0% | Open the original filing on SEC.gov |
| Sep 29 | ANRO | Alto Neuroscience, Inc. | MEXER◷?◆ | 54,375 | — | — | — | Open the original filing on SEC.gov |
| Sep 29 | ANRO | Alto Neuroscience, Inc. | MEXER◷?◆ | 56,455 | — | — | — | Open the original filing on SEC.gov |
| Sep 29 | ANRO | Alto Neuroscience, Inc. | SSELL◷? | 110,830 | $26.58 | $2.9M | -82.2% | Open the original filing on SEC.gov |
| Sep 29 | ANRO | Alto Neuroscience, Inc. | MEXER◷? | 54,375 | $2.35 | $127.8K | +67.5% | Open the original filing on SEC.gov |
| Sep 29 | ANRO | Alto Neuroscience, Inc. | MEXER◷? | 56,455 | $2.35 | $132.7K | +234.6% | Open the original filing on SEC.gov |
| Mar 1 | ANRO | Alto Neuroscience, Inc. | FTAX | 2,806 | $19.69 | $55.3K | -10.4% | Open the original filing on SEC.gov |
| Feb 11 | ANRO | Alto Neuroscience, Inc. | AGRANT◆ | 200,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 3, 2025 | ANRO | Alto Neuroscience, Inc. | DTOISS◆ | 135,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 3, 2025 | ANRO | Alto Neuroscience, Inc. | AGRANT◆ | 135,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 3, 2025 | ANRO | Alto Neuroscience, Inc. | DTOISS◆ | 90,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 3, 2025 | ANRO | Alto Neuroscience, Inc. | AGRANT◆ | 90,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 3, 2025 | ANRO | Alto Neuroscience, Inc. | DTOISS◆ | 202,329 | — | — | — | Open the original filing on SEC.gov |
| Jul 3, 2025 | ANRO | Alto Neuroscience, Inc. | AGRANT◆ | 202,329 | — | — | — | Open the original filing on SEC.gov |
| Jul 3, 2025 | ANRO | Alto Neuroscience, Inc. | DTOISS◆ | 33,833 | — | — | — | Open the original filing on SEC.gov |
| Jul 3, 2025 | ANRO | Alto Neuroscience, Inc. | AGRANT◆ | 33,833 | — | — | — | Open the original filing on SEC.gov |
| Jul 3, 2025 | ANRO | Alto Neuroscience, Inc. | DTOISS◆ | 44,962 | — | — | — | Open the original filing on SEC.gov |
| Jul 3, 2025 | ANRO | Alto Neuroscience, Inc. | AGRANT◆ | 44,962 | — | — | — | Open the original filing on SEC.gov |